Latest from LSU Stanley S. Scott Cancer Center

Strategic Alliance Partnership will strengthen outreach to cancer patients.

The evaluation of noncytotoxic agents for the treatment of epithelial ovarian cancer has produced encouraging findings in recent months, which has led to the approval of new agents with novel mechanisms of action and continuing studies into many more potential therapies.